期刊文献+

CD56 CgA Syn在92例原发食管小细胞癌中的表达及临床意义和预后分析 被引量:6

Expression of tissue neuronal cell adhesion molecule 56, chromogranin A, and synaptophysin and its relationship with clinicopathological features and prognosis in 92 Chinese patients with primary esophageal small cell carcinoma
下载PDF
导出
摘要 目的:探讨神经内分泌标志物突触素(synaptophysin,Syn)、神经细胞黏附分子56(neuronal cell adhesion molecules 56,CD56)、嗜铬粒蛋白A(chromogranin A,CgA)在92例食管小细胞癌(primary esophageal small cell carcinoma,PESC)中的表达,并分析其表达与患者临床病理特征和预后间关系。方法:采用免疫组织化学法(immunohistochemisty,IHC)检测PESC中CD56、CgA、Syn分子表达;logistic回归分析其与患者临床病理特征关系;Kaplan-Meier法、Cox多因素回归法进行单因素和多因素生存分析;Log-rank法比较各组间生存曲线差异。结果:食管下段癌组织中CgA阳性表达率高于食管中、上段(72.2%vs.41.1%vs.10.0%),且差异具有统计学意义(P=0.001)。CD56、CgA、Syn表达与患者性别(P=0.262,0.998,0.931)、年龄(P=0.250,0.998,0.703)、肿瘤浸润深度(P=0.253,0.997,0.061)、淋巴结有无转移(P=0.767,0.998,0.613)无关;N1、N0的PESC生存期差异无统计学意义(P=0.563);PESC混合鳞癌(HR=2.58;95%CI:1.11~5.98)及CgA阳性表达PESC(HR=1.87;95%CI:1.02~3.43)预后优于单纯PESC及CgA阴性表达患者。结论:CgA表达与PESC肿瘤部位有关;淋巴结有无转移不影响PESC患者预后;组织学类型及CgA表达是PESC患者预后独立影响因素。 Objective:To investigate the expression level of synaptophysin (Syn), tissue neuronal cell adhesion molecule 56 (CD56) and chromogranin A (CgA) in 92 primary esophageal small cell carcinoma (PESC) and to explore its repationship with clinicopathological features and clinical outcome. Methods:Immunohistochemical studies of CD56, CgA, and Syn were performed in 92 paraffin-embed-ded tissues with clinical-related information obtained from 500,000 esophageal and gastric cardia carcinoma databases established by Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital of Zhengzhou University in Henan, China. Binary logistic regression was used to analyze the correlations of CgA, Syn, and CD56 expression with clinicopathological features. Kaplan-Mei-er survival analysis and Cox proportional hazards regression models were performed for univariate and multivariate survival analyses. Log-rank test was used to compare the difference in survival rates. Results:The CgA-positive expression rate in PESC at lower segment of esophagus (72.2%) was higher than those at the middle and lower segments (41.1%, 10.0%) (P=0.001). The expression level of CD56, CgA, and Syn was not correlated with gender (P=0.262, 0.998, 0.931), age (P=0.250, 0.998, 0.703), tumor invasion (P=0.253, 0.997, 0.061), and lymph node metastasis (P=0.767, 0.998, 0.613). Univariate analysis showed no survival influence in patients with and without lymph node metastasis (P=0.563). Multivariate survival analysis showed that patients with PESC mixed squamous cell car-cinoma (HR=2.58;95%Cl, 1.11-5.98) and higher CgA protein expression (HR=1.87;95%Cl, 1.02-3.43) exhibited a longer survival time than those with pure PESC and without CgA expression. Conclusion:Tissue CgA level was associated with tumor location in PESC. His-tological type and tissue CgA expression were independent important prognostic factors, and lymph node metastasis exerted no influ-ence on survival in PESC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2017年第5期204-209,共6页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金委员会-广东省联合重大项目(编号:U1301227) 河南省教育厅高等学校重点科研项目(编号:15B320006)资助~~
关键词 原发食管小细胞癌 嗜铬粒蛋白A 预后 免疫组织化学 primary esophageal small cell carcinoma, chromogranin A, prognosis, immunohistochemistry
  • 相关文献

参考文献2

二级参考文献16

  • 1王志刚,窦科峰.肿瘤免疫逃逸与转化生长因子-β关系的研究进展[J].中华实验外科杂志,2005,22(4):511-512. 被引量:9
  • 2王准,封巍,郑晓,刘冠,徐裕金.食管小细胞癌的临床分析[J].中国癌症杂志,2006,16(6):508-510. 被引量:12
  • 3Pardoll DM.The blockade of immune checkpoints in cancer immunotherapy[J].Nat Rev Cancer,2012,12 (4):252-264.
  • 4Monaghan SF,Thakkar RK,Tran ML,et al.Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient[J].Shock,2012,38(2):117-122.
  • 5Liu Y,Zeng B,Zhang Z,et al.B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer[J].Clin Immunol,2008,129 (3):471-481.
  • 6Wu K,Kryczek I,Chen L,et al.Kupffer cell suppression of CD8 + T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions[J].Cancer Res,2009,69 (20):8067-8075.
  • 7Ghebeh H,Barhoush E,Tulbah A,et al.FOXP3 + Tregs and B7-H1 +/PD-1 + T lymphocytes co-infiltrate the tumor tissues of highrisk breast cancer patients:Implication for immunotherapy[J].BMC Cancer,2008,23(8):57-69.
  • 8朱云霞,陈成,黄建安.PD-1分子在肺癌恶性胸腔积液CD8+T细胞上的表达及其生物学意义[J].肿瘤,2010,30(9):778-781.
  • 9Fridman WH,Pages F,Sautes-Fridman C,et al.The immune contexture in human tumours:impact on clinical outcome[J].Nat Rev Cancer,2012,12(4):298-306.
  • 10Pardoll D,Drake C.Immunotherapy earns its spot in the ranks of cancer therapy[J].J Exp Med,2012,209(2):201-209.

共引文献20

同被引文献46

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部